harm reduction

Document library

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Stronger efforts are needed to improve data availability to guide an increase in HCV treatment among PWID.

Document library

Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis

Identifies key actions suggested by lessons learned from the three-plus decades of the HIV epidemic which can be applied to the prevention of hepatitis among drug users.

Document library

Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West

Despite the absolute differences in reported risk behaviours among PWID in western and eastern Europe, the associations of risk behaviours with HIV status were similar across the sites and regions. HIV prevention...

Video thumbnail: NPS nightlife settings

Interview: Responses to new psychoactive substances in nightlife settings

Information on health responses to the use of new psychoactive substances (NPS) is emerging but, in many cases, remains anecdotal. To mark World Drugs Day 2016 on 26 June, we will be...

Video thumbnail: naloxone

Video: Take-home naloxone programmes in Europe — overdose prevention

Drug overdose continues to be the main cause of death among problem drug users and heroin or its metabolites are present in the majority of reported fatal overdoses. Naloxone is a lifesaving...

Video thumbnail Drug consumption rooms

Video: Drug consumption rooms

Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades. These facilities primarily aim to reduce...

Video thumbnail: OST explained

Motion graphic: Opioid substitution treatment explained

The use of substitution drugs for the treatment of heroin dependence represents a key evidence-based response to heroin problems in Europe. The diversion of these medicines to non-medical use and sale on...

Document library

Fentanyls: are we missing the signs? Highly potent and on the rise in Europe

Fentanyl is a synthetic opioid analgesic historically used as a pain reliever and an anaesthetic. In the European context, fentanyls are ‘low use but high risk/harm’ substances. Developments in illicit supply of...

Document library

Quality assurance in drug demand reduction in European countries: an overview

This article examines the evidence for quality assurance systems for drugs-related interventions in Europe, based on information gathered by the EMCDDA.

Virus

EMCDDA and ECDC join forces to address the challenge of hepatitis

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EMCDDA in Lisbon from 12–16 June. The initiative brings together some 100 specialists in the...

Subscribe to harm reduction